Amgen dismisses bone density concerns related to its weight-loss drug
Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after those concerns wiped off more than $12 billion from the company's market value.
What are your questions about weight loss drugs?
Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight management but for many people, there are still questions around side effects, accessibility and results.
‘This Weight Loss Drug Helped My Mental Health Way More Than Any Other Medication’
The weight loss injection tirzepatide helped Melanie Ressa lose weight and overcome food noise, emotional eating, and mental health challenges. Her story, here.
Al Roker Says He’s 'Not Gonna Judge Anybody' Taking Weight Loss Drugs: 'It’s Unlike Any Other Addiction'
Al Roker opened up about food addiction and the use of trendy weight loss medications, admitting that he won’t judge those who turn to the drugs for help in their weight loss journeys
New Drug CagriSema May Lead to 10% More Weight Loss Than Wegovy or Ozempic
Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs Ozempic and Wegovy. Novo Nordisk, the manufacturer of both, recently shared that CagriSema may lead to 10 percent more weight loss than Wegovy.
Weight-loss drugs can help stroke survivors prevent recurrence
The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.
Amgen sees no bone safety concerns around experimental obesity drug
Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone mineral density, a day after data from an early-stage study dragged its stock 7% lower.
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Analysts cited data from a phase one study showing the highest dose of Amgen's MariTide was linked to roughly 4% loss of bone mineral density over 12 weeks.
Amgen rebounds after denying bone safety concerns linked to obesity drug
Amgen (NASDAQ:AMGN) shares spiked in the premarket on Wednesday after the company ruled out concerns over loss of bone mineral density linked to its obesity candidate MariTide, which led to a ~7% decline in its share price in the previous session.
Eat This%2c Not That!59m
9 Exercises Men Should Avoid for Weight Loss
Attention all men! Are you trying to lose weight? If so, you'll want to listen up. You may think you have a solid fitness ...
New York Post1h
NASA monitoring second stranded astronaut’s possible weight loss after raising alarm about colleague Sunita Williams’ health
And his mass seems to have gone down.” NASA is working to help astronaut Sunita Williams put on pounds after she had ...
Chantelle Houghton wows in a skimpy red bikini as she soaks up the sun in Tenerife after five stone weight loss
The former Celebrity Big Brother star, 41, wowed in a skimpy red bikini as she showcased her slimmed down frame after her ...
Weight Loss Injections: What You Need to Know, From Costs to Alternatives
Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...
'Today' host Al Roker says he doesn't judge anyone who uses Ozempic to lose weight
The "Today" host underwent gastric bypass surgery in 2002 to help him lose weight.
Hosted on MSN1h
Amgen dismisses bone density concerns related to its new weight-loss drug
(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, ...
6 high-fiber foods for weight loss
Ro explores the relationship between fiber and weight loss, six high-fiber foods for weight loss, and how incorporating these ...
Does Losing Weight Cause Hair Loss? Doctors Explain Why—And What You Can Do About It
If you’re noticing your hair is falling out amid losing weight, consider it your sign that you're not getting enough ...